デンソー、自己株式の取得状況に関するお知らせ

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2019年02月05日 16時00分

Source: Denso

デンソー、自己株式の取得状況に関するお知らせ

（会社法第165条第2項の規定による定款の定めに基づく自己株式の取得）

愛知, 2019年02月05日 - (JCN Newswire) - 当社は、2018年10月31日開催の取締役会において決議しました、会社法第165条第3項の規定により読み替えて適用される同法第156条の規定に基づく自己株式の取得について、下記のとおり実施しましたので、取得状況（途中経過）をお知らせします。

１．取得した株式の種類：普通株式

２．取得した株式の総数：69,000株

３．株式の取得価額の総額：328,181,300円

４．取得期間：2019年１月１日～ 2019年１月31日

本リリースの詳細は下記をご参照ください。
https://www.denso.com/jp/ja/news/news-releases/2018/20190205-02/

概要：株式会社デンソー

詳細は www.denso.com/jp/ をご覧ください。

Source: Denso
セクター: 自動車

Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

Lexus International

Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST

Toyota Motor Corporation

TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST

Toyota Motor Corporation

TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST

Mitsubishi Heavy Industries, Ltd.

World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST

Hitachi, Ltd.

Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST

Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST

NEC Corporation

NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST

Eisai

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST

HKTDC

The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST

Eisai

New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST

Mitsubishi Motors

Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST

Anime Tokyo Station

Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST

Eisai

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST

NEC Corporation

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST

Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST

Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST

Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST

Eisai

Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST

More Latest Release >>